Genia nails down $5.3M NIH grant for genome sequencing project

Genia Technologies has landed a $5.3 NIH grant to advance its genome sequencing technology. The company will use the money in its work with partners at Columbia University and Harvard Medical school to fund more development of NanoTag, its nanopore-based DNA sequencing platform. Genia CEO Stefan Roever told FierceBiotech Research that the goal is to take his technology from the research lab and put it in the hands of patients in order to sequence a wide variety of diseases. Story

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.